Among the 10 SNPs listed in Supplementary Table 4, proprotein convertase subtilisin/kexin type 9 (PCSK9), glucokinase regulator (GCKR), lipoprotein(a) (LPA), ZPR1 zinc finger (ZPR1), lipase C, hepatic type (LIPC), lipase G, endothelial type (LIPG), transmembrane 6 superfamily member 2 (TM6SF2), and MAU2 sister chromatid cohesion factor (MAU2) have been reported to be associated with lipid metabolism disorders. Here, MAU2 is linked to Disorder of lipid metabolism.